9
H index
8
i10 index
451
Citations
Laura Magazzini : Citation Profile
Scuola Superiore Sant'Anna | RESEARCH PRODUCTION: 19 Articles 38 Papers 1 Chapters RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
24 years (2001 - 2025). Relations with other researchers
Works with:
Authors registered in RePEc who have co-authored more than one work in the last five years with Laura Magazzini. | Is cited by:
| Cites to:
|
Main data
Where Laura Magazzini has published?
| Journals with more than one article published | # docs |
|---|---|
| Stata Journal | 3 |
| The European Journal of Health Economics | 2 |
| Econometric Reviews | 2 |
Recent works citing Laura Magazzini (2025 and 2024)
| Year | Title of citing document |
|---|---|
| 2024 | Valuing Pharmaceutical Drug Innovations. (2024). Farmer, Leland ; Aryal, Gaurab ; Ciliberto, Federico ; Khmelnitskaya, Ekaterina. In: Papers. RePEc:arx:papers:2212.07384. Full description at Econpapers || Download paper |
| 2025 | The evolving boundary of green technology. (2025). Barbieri, Nicolo ; Persoon, Peter ; Hotte, Kerstin. In: Papers. RePEc:arx:papers:2503.21310. Full description at Econpapers || Download paper |
| 2024 | Understanding the Link between Post‐Acquisition Resource Reconfiguration and Technology Out‐Licensing. (2024). Klueter, Thomas Maximilian ; Moreira, Solon ; Ofoedu, Clinton. In: Journal of Management Studies. RePEc:bla:jomstd:v:61:y:2024:i:5:p:2101-2136. Full description at Econpapers || Download paper |
| 2025 | Patent policy, invention and innovation in the theory of Schumpeterian growth. (2025). Klein, Michael A. In: Journal of Economic Dynamics and Control. RePEc:eee:dyncon:v:176:y:2025:i:c:s0165188925000788. Full description at Econpapers || Download paper |
| 2025 | Urban–rural disparities in hospital admissions for depression in Austria. (2025). Zuba, Martin ; Berger, Michael ; Simon, Judit. In: Health Policy. RePEc:eee:hepoli:v:151:y:2025:i:c:s0168851024002197. Full description at Econpapers || Download paper |
| 2024 | Leveraging intellectual property: The value of harmonized enforcement regimes. (2024). Heller, David ; Gill, Andrej. In: Journal of Banking & Finance. RePEc:eee:jbfina:v:163:y:2024:i:c:s0378426624000864. Full description at Econpapers || Download paper |
| 2025 | Timing, modifications, and tenor of firms mandatory R&D disclosures: The role of competition. (2025). Malik, Sumeet ; Rathee, Chandrika ; Salandra, Rossella. In: Research Policy. RePEc:eee:respol:v:54:y:2025:i:1:s0048733324001616. Full description at Econpapers || Download paper |
| 2025 | When the drugs (don’t) work: The role of science in product commercialization. (2025). Anckaert, Paul-Emmanuel. In: Research Policy. RePEc:eee:respol:v:54:y:2025:i:5:s0048733325000666. Full description at Econpapers || Download paper |
| 2025 | Autonomous inventions, problem formulation, and inventive outcomes. (2025). Sharapov, Dmitry ; Yang, Jiho ; Criscuolo, Paola. In: Research Policy. RePEc:eee:respol:v:54:y:2025:i:7:s0048733325001003. Full description at Econpapers || Download paper |
| 2024 | Pricing innovation: The anchoring effect in patent valuation. (2024). Wang, P. E. N. G. F. E. I., . In: Technovation. RePEc:eee:techno:v:136:y:2024:i:c:s0166497224001202. Full description at Econpapers || Download paper |
| 2025 | The marginal effect of external technologies on innovation speed under complexity. (2025). Lee, Yeolan ; Fong, Eric A. In: Technovation. RePEc:eee:techno:v:140:y:2025:i:c:s0166497224001950. Full description at Econpapers || Download paper |
| 2024 | The role of the quality infrastructure within socio-technical transformations: A European perspective. (2024). Blind, Knut. In: Technological Forecasting and Social Change. RePEc:eee:tefoso:v:199:y:2024:i:c:s0040162523007047. Full description at Econpapers || Download paper |
| 2024 | The impact of G7 trade policies on economic development in Africa. (2024). Wolf, Moritz. In: Jena Economics Research Papers. RePEc:jrp:jrpwrp:2024-005. Full description at Econpapers || Download paper |
| 2024 | R&D collaboration, social coordination, and standardization: evidence from the Chinese automotive industry. (2024). Pennings, Enrico ; Feng, KE ; Zeng, Deming ; Karreman, Bas. In: The Journal of Technology Transfer. RePEc:kap:jtecht:v:49:y:2024:i:1:d:10.1007_s10961-022-09972-8. Full description at Econpapers || Download paper |
| 2024 | Many are called, few are chosen: the role of science in drug development decisions. (2024). Belderbos, Rene ; Kelchtermans, Stijn ; Colen, Linde ; Leten, Bart. In: The Journal of Technology Transfer. RePEc:kap:jtecht:v:49:y:2024:i:2:d:10.1007_s10961-022-09982-6. Full description at Econpapers || Download paper |
| 2025 | Patent-based indicators for predicting patent commercialization: a study of the diffusion of pharmaceutical innovations. (2025). Jain, Sudhir K ; Krishna, Vinita. In: The Journal of Technology Transfer. RePEc:kap:jtecht:v:50:y:2025:i:1:d:10.1007_s10961-024-10087-5. Full description at Econpapers || Download paper |
| 2025 | Assessing the role of regional educational integration policies in fostering university-industry-research innovation: Evidence from China. (2025). Chen, QI ; Zhou, Jiawen. In: PLOS ONE. RePEc:plo:pone00:0325717. Full description at Econpapers || Download paper |
| 2024 | Effects of co-patenting across national boundaries on patent quality. An exploration in pharmaceuticals. (2024). Acosta, Manuel ; Medina, Jennifer ; Coronado, Daniel. In: MPRA Paper. RePEc:pra:mprapa:123322. Full description at Econpapers || Download paper |
| 2024 | Ex-ante estimating of additional remuneration for employee inventions: explanatory role of the weighted patent family size indicator. (2024). Svaina, Pavel ; Zouhar, Jan. In: Eurasian Business Review. RePEc:spr:eurasi:v:14:y:2024:i:1:d:10.1007_s40821-024-00257-8. Full description at Econpapers || Download paper |
| 2025 | The evolving boundary of green technology. (2025). Persoon, Peter ; Hotte, Kerstin ; Barbieri, Nicolao. In: SEEDS Working Papers. RePEc:srt:wpaper:0325. Full description at Econpapers || Download paper |
| 2025 | Pharmaceutical Regulation and Incentives for Innovation in an International Perspective. (2025). Dubois, Pierre. In: TSE Working Papers. RePEc:tse:wpaper:131002. Full description at Econpapers || Download paper |
| 2024 | Can we map innovation capabilities?. (2024). Gadgin Matha, Shreyas ; Hartog, Matte ; Raffo, Julio ; Moscatelli, Federico ; Rodriguez, Eduardo Hernandez ; Chacua, Christian ; Yildirim, Muhammed A. In: WIPO Economic Research Working Papers. RePEc:wip:wpaper:81. Full description at Econpapers || Download paper |
| 2025 | The impact of new millennium crises on the power of Islamic banks in deposit markets. (2025). Alhalboni, Maryam ; Baldwin, Kenneth. In: International Journal of Finance & Economics. RePEc:wly:ijfiec:v:30:y:2025:i:3:p:3230-3260. Full description at Econpapers || Download paper |
Works by Laura Magazzini:
| Year | Title | Type | Cited |
|---|---|---|---|
| 2019 | Does regulation drive international research cooperation? Evidence from the pharmaceutical sector In: The World Economy. [Full Text][Citation analysis] | article | 0 |
| 2022 | Exploring the nexus between appropriability and productivity in highly innovative and globalized companies In: Economics Virtual Symposium 2022. [Full Text][Citation analysis] | paper | 0 |
| 2025 | Exploring the nexus between appropriability and productivity in highly innovative and globalised companies.(2025) In: LEM Papers Series. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
| 2021 | An LM test for the mean stationarity assumption in dynamic panel-data models In: 2021 Stata Conference. [Full Text][Citation analysis] | paper | 1 |
| 2006 | Everything You Always Wanted to Know about Inventors (But Never Asked): Evidence from the PatVal-EU Survey In: CEPR Discussion Papers. [Full Text][Citation analysis] | paper | 33 |
| 2005 | Everything you Always Wanted to Know about Inventors (but Never Asked): Evidence from the PatVal-EU Survey.(2005) In: LEM Papers Series. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 33 | paper | |
| 2009 | A Breath of Fresh Air? Firm Type, Scale, Scope and Selection Effects in Drug Development. In: KITeS Working Papers. [Citation analysis] | paper | 46 |
| 2009 | A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development.(2009) In: Management Science. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 46 | article | |
| 2007 | A Breath of Fresh Air? Firm types, scale, scope and selection effects in drug development.(2007) In: MPRA Paper. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 46 | paper | |
| 2013 | Resale Price Maintenance: An Empirical Analysis of UK Firms Compliance In: Economic Journal. [Full Text][Citation analysis] | article | 1 |
| 2020 | Exploiting information from singletons in panel data analysis: A GMM approach In: Economics Letters. [Full Text][Citation analysis] | article | 2 |
| 2019 | Exploiting Information from Singletons in Panel Data Analysis: A GMM Approach.(2019) In: IZA Discussion Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 2 | paper | |
| 2025 | The 2023 European Commission proposal and the 2024 European Parliament proposal for the EU pharmaceutical legislation: policy content analysis In: Health Policy. [Full Text][Citation analysis] | article | 0 |
| 2021 | R&D and market size: Who benefits from orphan drug legislation? In: Journal of Health Economics. [Full Text][Citation analysis] | article | 4 |
| 2007 | Inventors and invention processes in Europe: Results from the PatVal-EU survey In: Research Policy. [Full Text][Citation analysis] | article | 190 |
| 2003 | Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sullIndustria e Distorsioni nel Funzionamento del Mercato In: Working Papers CERM. [Full Text][Citation analysis] | paper | 0 |
| 2005 | Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN In: Working Papers CERM. [Full Text][Citation analysis] | paper | 0 |
| 2014 | Dinamiche di mercato e intensità della concorrenza di prezzo nel segmento dei farmaci off patent. La posizione dellItalia nel contesto europeo. In: Working Papers CERM. [Full Text][Citation analysis] | paper | 0 |
| 2006 | La spesa farmaceutica pubblica - Analisi degli ultimi anni e indicazioni per una nuova politica economica In: Working Papers CERM. [Full Text][Citation analysis] | paper | 0 |
| 2007 | La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per lanalisi della variabilità regionale In: Working Papers CERM. [Full Text][Citation analysis] | paper | 4 |
| 2009 | Nuove politiche per linnovazione nel settore delle scienze della vita In: Working Papers CERM. [Full Text][Citation analysis] | paper | 0 |
| 2007 | Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico In: Working Papers CERM. [Full Text][Citation analysis] | paper | 0 |
| 2005 | Medical Devices: Competitiveness and Impact on Public Health Expenditure In: Working Papers CERM. [Full Text][Citation analysis] | paper | 18 |
| 2005 | Medical Devices Competitiveness and Impact on Public Health Expenditure.(2005) In: MPRA Paper. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 18 | paper | |
| 2012 | The Value of Failures in Pharmaceutical R&D In: Working Papers. [Full Text][Citation analysis] | paper | 4 |
| 2013 | R&D, Within and Between Patent Competition in the Pharmaceutical Industry In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2022 | The Identification of Time-Invariant Variables in Panel Data Model: Exploring the Role of Science in Firms’ Productivity In: IZA Discussion Papers. [Full Text][Citation analysis] | paper | 0 |
| 2004 | Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure In: MPRA Paper. [Full Text][Citation analysis] | paper | 19 |
| 2008 | The Sustainability of European Health Care Systems: Beyond Income and Ageing In: MPRA Paper. [Full Text][Citation analysis] | paper | 23 |
| 2012 | The sustainability of European health care systems: beyond income and aging.(2012) In: The European Journal of Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 23 | article | |
| 2008 | The Sustainability of European Health Care Systems: Beyond Income and Ageing.(2008) In: Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 23 | paper | |
| 2001 | Simulation-based estimation of Tobit model with random effects In: MPRA Paper. [Full Text][Citation analysis] | paper | 5 |
| 2002 | The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis In: Revue d'Économie Industrielle. [Full Text][Citation analysis] | article | 9 |
| 2023 | Linear Dynamic Panel Data Models: Exploring the Patent-R&D Relationship in Europe In: Contributions to Economics. [Citation analysis] | chapter | 0 |
| 2012 | Autocorrelation and masked heterogeneity in panel data models estimated by maximum likelihood In: Empirical Economics. [Full Text][Citation analysis] | article | 4 |
| 2009 | Autocorrelation and masked heterogeneity in panel data models estimated by maximum likelihood.(2009) In: Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 4 | paper | |
| 2004 | Dynamic competition in pharmaceuticals In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 23 |
| 2016 | Learning from successes and failures in pharmaceutical R&D In: Journal of Evolutionary Economics. [Full Text][Citation analysis] | article | 5 |
| 2023 | Assessing individual skill influence on housework time of Italian women: an endogenous-switching approach In: Statistical Methods & Applications. [Full Text][Citation analysis] | article | 0 |
| 2009 | Patent disclosure and R&D competition in pharmaceuticals In: Economics of Innovation and New Technology. [Full Text][Citation analysis] | article | 8 |
| 2009 | Patent Disclosure and R&D Competition in Pharmaceuticals..(2009) In: DISA Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 8 | paper | |
| 2009 | Patent Disclosure and R&D Competition in Pharmaceuticals..(2009) In: ROCK Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 8 | paper | |
| 2019 | Testing initial conditions in dynamic panel data models In: Econometric Reviews. [Full Text][Citation analysis] | article | 3 |
| 2020 | Testing initial conditions in dynamic panel data models.(2020) In: Econometric Reviews. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 3 | article | |
| 2020 | Using information from singletons in fixed-effects estimation: xtfesing In: Stata Journal. [Full Text][Citation analysis] | article | 0 |
| 2021 | Maximum likelihood estimation of an across-regime correlation parameter In: Stata Journal. [Full Text][Citation analysis] | article | 0 |
| 2023 | A Lagrange multiplier test for the mean stationarity assumption in dynamic panel-data models In: Stata Journal. [Full Text][Citation analysis] | article | 1 |
| 2011 | International Cooperation in Pharmaceutical Research In: Working Paper series, University of East Anglia, Centre for Competition Policy (CCP). [Full Text][Citation analysis] | paper | 0 |
| 2009 | International Cooperation in Pharmaceutical Research.(2009) In: Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
| 2011 | Moment Conditions and Neglected Endogeneity in Panel Data Models In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2018 | The Joint Estimate of Singleton and Longitudinal Observations: a GMM Approach for Improved Efficiency In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2010 | The productivity crisis in pharmaceutical R&D In: Working Papers. [Full Text][Citation analysis] | paper | 41 |
| 2012 | Identification of linear panel data models when instruments are not available In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2019 | R&D and market size: who benefits from orphan drug regulation? In: Working Papers. [Full Text][Citation analysis] | paper | 1 |
| 2014 | Improving GMM efficiency in dynamic models for panel data with mean stationarity In: Working Papers. [Full Text][Citation analysis] | paper | 1 |
| 2013 | A powerful test of mean stationarity in dynamic models for panel data: Monte Carlo evidence In: Working Papers. [Full Text][Citation analysis] | paper | 2 |
| 2010 | Negative variance estimates in panel data models In: Working Papers. [Full Text][Citation analysis] | paper | 3 |
| 2008 | Patent Value and R&D Competition In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated December, 22 2025. Contact: CitEc Team